SentryDx的封面图片
SentryDx

SentryDx

医疗和诊断实验室

White Bear Lake,Minnesota 47 位关注者

Accurately diagnosing residual cancer from a blood draw

关于我们

NexGen accurately detects cancer DNA from a simple blood draw (liquid biopsy). Cancer DNA is rare, but NexGen's technology makes detection easy. NexGen takes a blood sample and replicates the DNA, like PCR, but adds a blocker to prevent normal DNA from replicating. This allows for the enrichment and easy detection of cancer DNA. Liquid biopsies can detect cancer up to 16 months before the current standard, which is radiological imaging. Early detection will lead to better treatment and saves millions of lives. NexGen's goal is to receive FDA approval for diagnosing cancer from a blood draw and is uniquely positions, compared to many competitors, to meet the FDA's guidance on in vitro diagnostic regulation.

网站
https://sentrydx.com/
所属行业
医疗和诊断实验室
规模
2-10 人
总部
White Bear Lake,Minnesota
类型
合营企业
创立
2021

地点

  • 主要

    1793 Buerkle Circle

    US,Minnesota,White Bear Lake,55110

    获取路线

SentryDx员工

相似主页